SCHEMBL4485254

SCHEMBL4485254

CCOC(=O)C1=C(NCCC(C)C)CCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC26A6 Q9BXS9 1/20 0.42
ALDH1A1 P00352 8/20 0.39
MAPT P10636 7/20 0.37
KDM4E B2RXH2 6/20 0.37
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
ALOX15 P16050 3/20 0.37
CAPN9 O14815 1/20 0.36
LMNA P02545 2/20 0.35
NPSR1 Q6W5P4 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
TSHR P16473 2/20 0.35
GAA P10253 4/20 0.35
HPGD P15428 4/20 0.35
CYP2D6 P10635 1/20 0.35
POLB P06746 1/20 0.35
RECQL P46063 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13712262 0.97 SLC26A6 (0.42) SLC26A6ALDH1A1MAPTKDM4EMEN1
SCHEMBL4492930 0.82 MAPT (0.43) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL4487412 0.80 MAPT (0.42) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL4483166 0.80 MEN1 (0.38) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL4481587 0.80 MAPT (0.37) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL12777592 0.78 NLRP3 (0.41) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL14752782 0.78 MAPT (0.40) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL13374643 0.77 MAPT (0.42) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL4495971 0.77 MAPT (0.44) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL11276545 0.75 PTGS2 (0.43) ALDH1A1MAPTKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582626-B2 5,6-dihydro-1H-pyridin-2-one compounds ANADYS PHARMACEUTICALS, INC. (US) 2009-09-01 US disclosed
US-7582626-B2 5,6-dihydro-1H-pyridin-2-one compounds ANADYS PHARMACEUTICALS, INC. (US) 2009-09-01 US disclosed
US-7582626-B2 5,6-dihydro-1H-pyridin-2-one compounds ANADYS PHARMACEUTICALS, INC. (US) 2009-09-01 US disclosed
US-20090111798-A1 5,6-DIHYDRO-1H-PYRIDIN-2-ONE COMPOUNDS ANADYS PHARMACEUTICALS, INC. 2009-04-30 US disclosed
US-20090111798-A1 5,6-DIHYDRO-1H-PYRIDIN-2-ONE COMPOUNDS ANADYS PHARMACEUTICALS, INC. 2009-04-30 US disclosed
US-20090111798-A1 5,6-DIHYDRO-1H-PYRIDIN-2-ONE COMPOUNDS ANADYS PHARMACEUTICALS, INC. 2009-04-30 US disclosed
WO-2008073982-A2 5,6-DIHYDRO-1H-PYRIDIN-2-ONE COMPOUNDS ANADYS PHARMACEUTICALS, INC. (US) 2008-06-19 WO disclosed
WO-2008073982-A2 5,6-DIHYDRO-1H-PYRIDIN-2-ONE COMPOUNDS ANADYS PHARMACEUTICALS, INC. (US) 2008-06-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090111798-A1 5,6-DIHYDRO-1H-PYRIDIN-2-ONE COMPOUNDS HAVCR2, PYGL, HCCS SLC26A6 1986/4885ALDH1A1 417/4885MAPT 1418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.